On July 14, Liquidia rose 5.21% in regular trading, trading at $74.78/share, with Turnover of $22.53 million.
Within the Pharmacy sector where Liquidia belongs, the overall sector performance was weak. Among individual stocks, Eli Lilly down 2.47%, Johnson & Johnson down 1.87%, Pfizer down 1.14%, Merck down 2.37%, AstraZeneca PLC down 2.26%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)